CYTX Short Information, Cytori Therapeutics Inc.

Twenty Trading Day Totals
Total Shorted Volume	2,423,093
Total Actual Volume	16,136,579

Averages
Average Short Volume	121,155
Average Short Percentage	37.09%

Is there a CYTX Short Squeeze or Breakout about to happen?

See the CYTX Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2019-07-26	0.2265	0.2077	0.2265	0.2043	444,060	23,251	16.1132
2019-07-25	0.2269	0.21999	0.2269	0.21	320,790	900	1.1512
2019-07-24	0.222	0.227	0.233	0.22	91,681	11,041	51.2367
2019-07-23	0.233	0.233004	0.2425	0.22	142,564	369	2.2676
2019-07-22	0.231	0.23	0.2402	0.23	234,090	970	0.9843
2019-07-19	0.24	0.2375	0.241	0.23	136,561	5,284	7.5034
2019-07-18	0.2335	0.2401	0.243	0.2311	182,818	19,825	26.0031
2019-07-17	0.2356	0.231389	0.2596	0.23	320,331	5,924	8.2660
2019-07-16	0.25	0.2401	0.25	0.228	769,908	67,988	50.7563
2019-07-15	0.237	0.265	0.2945	0.23	2,107,721	753,663	55.0424
2019-07-12	0.24	0.2324	0.24	0.228	233,793	35,360	60.9508
2019-07-11	0.24	0.237	0.24	0.228	259,518	36,764	42.4988
2019-07-10	0.227	0.2374	0.2375	0.2075	501,231	67,054	47.2734
2019-07-09	0.2312	0.2197	0.2312	0.2155	444,527	57,417	66.0345
2019-07-08	0.2349	0.2201	0.2349	0.21	692,223	75,429	61.9255
2019-07-05	0.247	0.2349	0.25	0.23	269,055	21,601	36.5611
2019-07-03	0.23	0.247	0.248	0.229	350,790	40,714	69.3158
2019-07-02	0.2748	0.2489	0.275	0.229	1,538,027	136,566	42.5059
2019-07-01	0.28	0.28	0.34	0.2604	6,944,740	1,043,072	53.7246
2019-06-28	0.2484	0.2423	0.25	0.231	152,151	19,901	41.7553

Stock Information

Cytori Therapeutics Inc. Company Name:

CYTX Stock Symbol:

NASDAQ Market:

Cytori Therapeutics Inc. Website:

CYTX Short Information, Cytori Therapeutics Inc.

Get CYTX Alerts

News, Short Squeeze, Breakout and More Instantly...

CYTX - Cytori Will Become Plus Therapeutics, Inc.

AUSTIN, Texas, July 16, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX) (the “company”) announced yesterday a new direction and identity. Since the beginning of 2019, the company has successfully evaluated and transformed its pipeline to place a stronger e...
CYTX - Cytori to Present Corporate Update & New Strategic Direction

SAN DIEGO, July 11, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) “the Company” will provide a live webcast to discuss its new company direction following two recent asset sales and highlight key anticipated milestones on July 15, 2019 at 4:30 PM Eastern Ti...
CYTX - Cytori Reports Summary of FDA Feedback Regarding its ATI-1123 Product

AUSTIN, Texas, July 01, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) today provided an update on the development of its proprietary drug, ATI-1123, based on recently obtained feedback from the United States Food and Drug Administration (FDA). ATI-1123 is a substantially...